Home/Filings/4/0001209191-19-056637
4//SEC Filing

Hoof Torsten 4

Accession 0001209191-19-056637

CIK 0001131324other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 9:42 PM ET

Size

19.6 KB

Accession

0001209191-19-056637

Insider Transaction Report

Form 4
Period: 2019-11-08
Hoof Torsten
Chief Int'l Commercial Officer
Transactions
  • Disposition to Issuer

    Common Stock

    2019-11-0810,3880 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-0811,5000 total
    Exercise: $31.78Exp: 2027-09-01Common Stock (11,500 underlying)
  • Disposition to Issuer

    Common Stock

    2019-11-084,47910,388 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-085,75011,500 total
    Exercise: $31.78Exp: 2027-09-01Common Stock (5,750 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-081,9805,940 total
    Exercise: $33.21Exp: 2028-01-31Common Stock (1,980 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-085,9400 total
    Exercise: $33.21Exp: 2028-01-31Common Stock (5,940 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy) Holding

    2019-11-0810,9500 total
    Exercise: $72.52Exp: 2029-01-29Common Stock (10,950 underlying)
Footnotes (7)
  • [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $123,214 and 2,017 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F2]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 7,949 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $82,937.52, less applicable tax withholdings, and 1,358 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 8,801 shares of Exact Sciences common stock with an exercise price of $41.53 per share.
  • [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $27,394, less applicable tax withholdings, and 448 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
  • [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 4,546 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
  • [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 8,380 shares of Exact Sciences common stock with an exercise price of $94.76 per share.

Issuer

GENOMIC HEALTH INC

CIK 0001131324

Entity typeother

Related Parties

1
  • filerCIK 0001774167

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:42 PM ET
Size
19.6 KB